Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study-Reference-Cited by-同舟云学术

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study

Published:2022-07 Issue: Volume:105 Page:103706
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Valerio Heather,Alavi Maryam,Conway Anna^ORCID,Silk David,Treloar Carla,Martinello Marianne,Milat Andrew,Dunlop Adrian^ORCID,Murray Carolyn^ORCID,Henderson Charles,Amin Janaki,Read Phillip,Marks Philippa,Degenhardt Louisa^ORCID,Stevens Annabelle,Prain Bianca,Hayllar Jeremy,Reid David,Montebello Mark^ORCID,Wade Alexandra,Christmass Michael^ORCID,Cock Victoria,Dore Gregory J,Grebely Jason^ORCID

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference47 articles.

1. Novel hepatitic C virus (HCV) diagnosis and treatment delivery systems: Facilitating HCV elimination by thinking outside the clinic;Bajis;Journal of Infectious Diseases,2020

2. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study;Bajis;Journal of Viral Hepatitis,2019

3. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia;Bajis;International Journal of Drug Policy,2018

4. The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; Real-World Data 2011-2018;Bardsley;Journal of Viral Hepatitis,2021

5. Impact of COVID-19 on global HCV elimination efforts;Blach;Journal of Hepatology,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of hepatitis C virus exposure and infection among Indigenous and tribal populations: a global systematic review and meta-analysis;Public Health;2024-08

2. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study;Eurosurveillance;2024-07-18

3. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study;International Journal of Drug Policy;2024-07

4. Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era;International Journal of Drug Policy;2024-06

5. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs;International Journal of Drug Policy;2024-06